top
Search terms
Results 1 - 10 of 53 - ordered by :
Pages: 1 2 3 4 5 6 ... 6
Heart

Previous trials (for example, PROVE-IT) have demonstrated that lowering low density lipoprotein (LDL) cholesterol below currently recommended values is beneficial in patients with acute coronary ...

Heart, JournalScan, Iqbal Malik

Date : 01/06/2005
Ejhf

Aims In patients with heart failure (HF), serum erythropoietin (EPO) levels are elevated and associated with disease severity and outcome. Methods and results Serum EPO levels were measured at ...

European Journal of Heart Failure, Grote Beverborg, Niels, van der Wal, Haye H., Klip, IJsbrand T., Voors, Adriaan A., de Boer, Rudolf A., van Gilst, Wiek H., van Veldhuisen, Dirk J., Gansevoort, Ron ...

Date : 01/07/2016 Item size : 57626 bytes
Eurointervention

EuroIntervention Vasodilating beta-blockers are superior to conventional beta-blockers in preventing major cardiovascular events in patients with myocardial infarct (from the Korea Acute Myocardial ...

Date : 06/05/2016 Item size : 33502 bytes
Eurointervention

EuroIntervention Prediction of major adverse cardiovascular events using annual coronary artery calcium score progression rate combined with baseline coronary artery calcium score in an asymptomatic ...

Date : 06/05/2016 Item size : 31856 bytes
Ehjournal

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The management and, as a consequence, the outcome of acute coronary syndromes or ACS have improved impressively over the last ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/04/2016 Item size : 257926 bytes
Ehjournal

The Framingham study and numerous cohorts thereafter subsequently confirmed the prognostic value of cholesterol and in particular LDL-cholesterol, and the 4S Trial2 eventually proved the cholesterol ...

European Heart Journal, Issue @ A Glance, Thomas F. Lüscher

Date : 14/10/2016 Item size : 197432 bytes
Ehjournal

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a new class of drugs able to decrease LDL-C by 5070% when administered either as a monotherapy or on a background with statins.46 ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/09/2015
Epeuropace

Application of Vaughan-Williams class Ic antiarrhythmic drugs in patients with atrial fibrillation suffering from coronary artery disease is limited due to severe side effects. In this post hoc ...

Europace, Atrial fibrillation, Ron Pisters, Stefan H. Hohnloser, Stuart J. Connolly, Christian Torp-Pedersen, Lisa Naditch-Brûlé, Richard L. Page, Harry J.G.M. Crijns, for the ATHENA ...

Date : 01/02/2014
Heart

C J Currie1, C D Poole2, P Conway3 1Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK 2Pharmatelligence, Cardiff, UK 3Health Economics, Wyeth Europa Limited, Maidenhead, UK ...

Heart, Epidemiology, C J Currie, C D Poole, P Conway

Date : 01/04/2008
Heart

Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study N K Wenger1, S J Lewis2, F K ...

Heart, Coronary artery disease, N K Wenger, S J Lewis, F K Welty, D M Herrington, V Bittner

Date : 01/04/2008